MoneyWorks4Me

Cadila Healthcare informs about press release

02 May 2020 Evaluate

Cadila Healthcare has informed that the company enclosed a Press Release dated May 2, 2020 titled ‘Zydus receives tentative approval from the USFDA for Empagliflozin and Metformin Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..